Back to Rubric Capital Management LP

Rubric Capital Management LP

All holdings · as of Dec 31, 2025

76 positions

CompanyClassValueShares% of portfolio
Talen Energy Corp$1.35B3,602,17116.1%
FTAI Aviation Ltd$728.35M3,700,0008.7%
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVAADR$666.51M21,355,5108.0%
GOLAR LNG LTD$341.55M9,178,9784.1%
Vistra Corp.$322.66M2,000,0003.9%
Viatris Inc$317.48M25,500,0003.8%
Arcutis Biotherapeutics, Inc.$240.21M8,271,5772.9%
Constellation Energy Corp$236.69M670,0002.8%
TRANSALTA CORP$224.76M17,781,3252.7%
Roivant Sciences Ltd.$195.30M9,000,0002.3%
MERCURY GENERAL CORP$193.25M2,054,5042.3%
BGC Group Inc$187.53M21,000,0002.2%
Fluor Corp$164.22M4,143,8082.0%
Amneal Pharmaceuticals, Inc.$155.42M12,334,9411.9%
ZYMEWORKS INC.$151.40M5,750,0001.8%
Kiniksa Pharmaceuticals International, plc$137.31M3,328,6531.6%
LIBERTY GLOBAL LTD$111.61M10,018,4321.3%
QuidelOrtho Corp$107.88M3,777,1571.3%
Akamai Technologies Inc$104.70M1,200,0001.3%
Ecovyst Inc.$102.17M10,500,0001.2%
CIMPRESS plc$101.55M1,525,0001.2%
INTEGRA LIFESCIENCES HOLDINGS CORP$96.30M7,753,9341.2%
Delek US Holdings, Inc.$79.71M2,687,4491.0%
LIBERTY LATIN AMERICA LTD$79.50M10,656,9351.0%
Telephone and Data Systems Inc$75.85M1,850,0000.9%
Schrodinger, Inc.$74.59M4,171,4980.9%
Eos Energy Enterprises, Inc.$74.49M6,500,0000.9%
Compass, Inc.$73.99M7,000,0000.9%
Adeia Inc.$73.90M4,284,2050.9%
ARS Pharmaceuticals, Inc.$72.23M6,200,0000.9%
COLLEGIUM PHARMACEUTICAL, INC.$69.28M1,496,4360.8%
LIBERTY GLOBAL LTD$67.58M6,121,5820.8%
Enovis CORP$65.35M2,453,2650.8%
STRATASYS LTD$63.71M7,340,0260.8%
Archer-Daniels-Midland Co$63.33M1,101,5830.8%
RENEW ENERGY GLOBAL PLC$62.15M11,000,0000.7%
Bunge Global SA$60.26M676,5100.7%
OPKO HEALTH, INC.OPKCommon Stock$60.22M47,791,2430.7%
Primo Brands Corp$59.33M3,628,8150.7%
Proto Labs Inc$56.83M1,123,3380.7%
Orthofix Medical Inc.$56.42M3,721,7150.7%
GEO GROUP INC$56.21M3,486,9150.7%
Andersons, Inc.$53.47M1,005,6310.6%
MEIRAGTX HLDGS PLC$49.09M6,175,3310.6%
Mativ Holdings Inc$48.39M3,982,4420.6%
NEWELL BRANDS INC.$48.36M13,000,0000.6%
Trevi Therapeutics, Inc.$47.16M3,766,7490.6%
Nurix Therapeutics, Inc.$46.93M2,473,8850.6%
MANNKIND CORP$42.39M7,476,4950.5%
HERON THERAPEUTICS, INC. /DE$39.06M30,046,8280.5%
← PrevPage 1 of 2Next →